NIH-funded research R01 grant

How HIV and long-term HIV medicines affect brain circuits

Official title: The effects of cART and HIV-1 infection on neural circuitry

Funded at State University New York Stony Brook · NIH-11263633 · Data updated 2026-11-12

This project is mapping how HIV infection and long-term antiretroviral medicines may change brain activity linked to thinking and memory in people with HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook
NIH-funded
Lab location1 site (Stony Brook, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2029
Funding year2026
Award (this year)$733,977
NIH project number5R01MH134776-03
Project IDNIH-11263633 on NIH RePORTER

Who could benefit from this research

Could help

People living with HIV who are taking long-term antiretroviral therapy and who are experiencing memory or thinking difficulties are the most relevant group for this research.

Less likely to help

People without HIV who are not using antiretroviral drugs are unlikely to receive direct benefit from this mouse-based work.

What this research studies

From a patient's perspective, researchers will use mouse models to mimic HIV infection, long-term antiretroviral (ARV) exposure, and the combination of both, then give the animals cognitive tasks to trigger brain activity. They will apply new 3D whole-brain mapping tools to identify which neural circuits light up or change after these exposures. The team will compare patterns across groups to find shared circuit changes and unique signatures tied to ARVs, HIV, or both. Findings aim to point to specific brain regions and pathways that could explain cognitive problems seen in people living with HIV.

Why it matters

Potential benefit: If successful, this work could identify brain circuits harmed by HIV or long-term ARV use and suggest targets to prevent or treat thinking and memory problems.

How similar studies have gone: Related animal-mapping approaches have provided useful insights into brain circuits, but applying 3D whole-brain activation mapping to ARV and HIV effects is relatively new and not yet linked to clinical treatments.

Where this research is happening

  • State University New York Stony Brook
    Stony Brook, United States
    Active

Researchers

  • Principal investigator: Enikolopov, Grigori N — State University New York Stony Brook
  • Study coordinator: Enikolopov, Grigori N

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.